Case Report: Pulmonary sarcomatoid carcinoma complicating TP53 mutation treated successfully with Tislelizumab combined with Anlotinib—a case report

Pulmonary sarcomatoid carcinoma (PSC) is a rare subtype of lung malignant tumor. Conventional chemotherapy has a suboptimal effectiveness. PSC has the characteristics of rapid disease progression and poor prognosis. We herein report a 56-year-old male patient with substantial smoking history was pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yu-Feng, Zhao, Xin-Fei, Tian, Yue, Xiao, Xin-Yao, Yan, Cai-Yun, Shen, Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Genetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9355298/
https://www.ncbi.nlm.nih.gov/pubmed/35938033
http://dx.doi.org/10.3389/fgene.2022.949989

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9355298/
https://www.ncbi.nlm.nih.gov/pubmed/35938033
http://dx.doi.org/10.3389/fgene.2022.949989

Ejemplares similares